InsiderTrades.com logo
Seattle Cannabis Company Capitalizes on Surging Demand
From All Marijuana Stocks   |   Ad
The increase in the number of states that permit recreational and medical use of cannabis means that growers, processors and manufacturers of cannabis products often can't keep up with growing demand. One Seattle weed manufacturer is poised to sell products across state lines, easing shortages. This could drive the company's shares sky-high.
Get all the details on this potential blockbuster!

RNO Insider Trading (Rhinomed)

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): A$336,033.11
Insider Selling (Last 12 Months): A$0.00

Rhinomed Insider Trading History Chart

This chart shows the insider buying and selling history at Rhinomed by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Rhinomed Share Price & Price History

Current Price: A$0.00
Price Change: +0.30 (1.20%)
As of 05/13/2020 01:00 AM ET

This chart shows the closing price history over time for RNO up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Infused Beverage Market is Hot
From Green Leaf Stock Journal   |   Ad
This company's disruptive model is helping build the foundation of the new social economy
Click here to see it.

Rhinomed Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
7/2/2021John McBainInsiderBuy487,921A$0.16A$77,091.52
6/24/2021John McBainInsiderBuy506,167A$0.15A$75,925.05
12/23/2020Michael JohnsonInsiderIssued12,690,457A$0.17A$2,093,925.41
12/21/2020Ronald (Ron) DewhurstInsiderBuy1,000,000A$0.18A$180,000.00
12/14/2020Michael JohnsonInsiderBuy16,666A$0.18A$3,016.55
9/22/2020Ronald (Ron) DewhurstInsiderBuy250,000A$0.14A$33,750.00
6/26/2020Michael JohnsonInsiderIssued75,112A$0.08A$5,783.62
3/25/2020Ronald (Ron) DewhurstInsiderBuy300,000A$0.07A$21,000.00
1/24/2020Eric KnightInsiderIssued1,000,000A$0.18A$180,000.00
1/2/2019Ronald (Ron) DewhurstInsiderBuy40,558A$0.19A$7,503.23
12/21/2018Michael JohnsonInsiderIssued71,386A$0.21A$14,991.06
See Full Table
Insider Selling at Rhinomed?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Rhinomed and related companies.

SEC Filings (Institutional Ownership Changes) for Rhinomed (ASX:RNO)

Rhinomed Limited engages in the research, development, and commercialization of consumer and medical devices worldwide. It identifies, acquires, and commercializes nasal stent delivery technologies. The company's product portfolio includes Turbine for enhanced breathing in sports; Mute, an anti-snoring device; and Pronto for nasal congestion and sleep disturbance issues. It also engages in developing applications for the delivery of medical cannabis and conditions, including anxiety, pain, allergies, nausea, anxiety, and coughs and colds; and nasal swab to test the presence of upper respiratory tract diseases, including influenza, and coronavirus strains. The company was formerly known as Consegna Group Limited and changed its name to Rhinomed Limited in November 2013. Rhinomed Limited was incorporated in 2004 and is based in Richmond, Australia.
Read More on Rhinomed

Today's Range

Now: N/A

50 Day Range

MA: N/A

52 Week Range

Now: N/A

Volume

452,773 shs

Average Volume

N/A

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Rhinomed?

Rhinomed's top insider investors include:
  1. Eric Knight (Insider)
  2. John McBain (Insider)
  3. Michael Johnson (Insider)
  4. Ronald (Ron) Dewhurst (Insider)
Seattle Cannabis Company Capitalizes on Surging Demand
From All Marijuana Stocks   |   Ad
The increase in the number of states that permit recreational and medical use of cannabis means that growers, processors and manufacturers of cannabis products often can't keep up with growing demand. One Seattle weed manufacturer is poised to sell products across state lines, easing shortages. This could drive the company's shares sky-high.
Get all the details on this potential blockbuster!